Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT00447005
Eligibility Criteria:
Inclusion Criteria:
* Patients histologically or cytologically diagnosed with advanced malignant solid tumors
* Patients for whom standard therapies have not been effective, or for whom there are no suitable therapies
Exclusion Criteria:
* Central lung lesions involving major blood vessels
* Patients who have been treated with bevacizumab or other VEGFR inhibitor(s)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00447005
Study Brief:
Protocol Section:
NCT00447005